Circulating GDF15 levels are elevated in individuals with obesity and are even higher in those with obesity and T2D, which may reflect a compensatory anti-inflammatory mechanism during early stages of metabolic disease (Carstensen et al. 2010). This evidence concerns the gene GDF15 and type 2 diabetes mellitus.